4processed
Form 4 — Insider Transaction
Maze Therapeutics, Inc.(MAZE)
Filing Date
May 14, 2026
Accepted
May 14, 2026
Accession No.
0002050172-26-000021
CIK
0001842295
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Bernstein Harold | President, R&D & CMO | Other | 15.0K | $10.42 | — | 15.0K | Common Stock | May 14, 2026 |
| Bernstein Harold | President, R&D & CMO | Other | 15.0K | $26.224 | — | 0 | Common Stock | May 14, 2026 |
| Bernstein Harold | President, R&D & CMO | Other | 15.0K | $0 | — | 222.4K | Stock Option (Right to Buy) | May 14, 2026 |